Alpa Laboratories Ltd

NSE
ALPA •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Alpa Laboratories Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
107.85% Gain from 52W Low
3.7
TTM PE Ratio
Below industry Median
12.2
Price to Book Ratio
Below industry Median
1.6
Dividend yield 1yr %
0
TTM PEG Ratio
0
RSI
RSI is mid-range
52
MFI
MFI is mid-range
66

Alpa Laboratories Ltd Key Financials

*All values are in ₹ Cr.

Alpa Laboratories Ltd shareholding Pattern

Promoter
57.3%
Foreign Institutions
1%
Public
41.7%

Alpa Laboratories Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
104.50
10Day EMA
104.00
12Day EMA
103.90
20Day EMA
103.80
26Day EMA
103.60
50Day EMA
101.80
100Day EMA
95.70
200Day EMA
86.30
Delivery & Volume
Resistance & Support
105.45
Pivot
Resistance
First Resistance
106.90
Second Resistance
109.25
Third Resistance
110.70
Support
First Support
103.10
Second support
101.65
Third Support
99.30
Relative Strength Index
52.03
Money Flow Index
66.04
MACD
0.32
MACD Signal
0.11
Average True Range
5.32
Average Directional Index
19.01
Rate of Change (21)
4.65
Rate of Change (125)
47.88

Alpa Laboratories Ltd Company background

Founded in: 1988
Managing director: Paresh Chawla
M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In 1998, the Company was converted into a Public Limited Company with effect from September 3, 1998 with the name of Alpa Laboratories Limited. The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels.In 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. The company has manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark Alpa which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. The company has also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, the company has also undertaken contract manufacturing of a large variety of pharmaceuticals.The company has manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. The company has an established productmarketing network covering both metro and mini metro cities, which enable company to reach the existing and potential customers through the network of distributors and dealers spread across the country. For the purpose of marketing the various products, the companys business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division.The Company came out with an Initial Public Offer in July 2007 and got listed on The n The Bombay Stock Exchange and The National Stock Exchange on 06lh August, 2008.The UnitII oral solid dosage manufacturing facility focusing on containment products such as oral hormonal and other oral hipotency formulations was made operational at Pithampur Industrial Area in 2012.The Company in FY 201415, acquired 100% of the shares of Norfolk Mercantile Private Limited making it a wholly owned subsidiary.
Read More

Alpa Laboratories Ltd FAQs

Alpa Laboratories Ltd shares are currently priced at 104.55 on NSE and 104.85 on BSE as of 2/21/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Alpa Laboratories Ltd [ALPA] share was 77.05. The Alpa Laboratories Ltd [ALPA] share hit a 1-year low of Rs. 50.3 and a 1-year high of Rs. 115.

The market cap of Alpa Laboratories Ltd is Rs. 219.97 Cr. as of 2/21/2024 12:00:00 AM.

The PE ratios of Alpa Laboratories Ltd is 12.34 as of 2/21/2024 12:00:00 AM.

The PB ratios of Alpa Laboratories Ltd is 1.43 as of 2/21/2024 12:00:00 AM

You can easily buy Alpa Laboratories Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage